Rocket Lab (RKLB) stock lost 25.5% in the week to October 16, 2026, sharply underperforming a 1.9% slip for the S&P 500. Amid that decline, on October 14, the company delayed the first launch of Neutron, its larger new rocket, to 2027. Reuters reported that the shares fell about 6% in extended trading on the news. When the whole market turned in the past, how far did Rocket Lab stock fall?

In Market Shocks, Rocket Lab Fell Far More

During the 2022 shock of high inflation and Fed tightening, Rocket Lab stock fell 70% while the S&P 500 lost 24%. That decline stands as the deepest among the five market shocks the stock has traded through since 2022. Across all five periods, the stock posted an average fall of 37.2%, compared to 13.4% for the index. Based on that record, a market shock has hit Rocket Lab stock close to three times as hard as the index.

Despite the severe drops, the stock managed to reach its old peak close after each of those falls. Investors experienced a median wait of 2 months from the lowest close. After the 2022 fall, however, the wait stretched to around 28 months.

A fall like this hurts most when Rocket Lab is a large share of what you own. See how to protect a concentrated position.

Rocket Lab Still Loses Money But Holds Cash

Rocket Lab is operating as a bigger business than it was a year ago, yet it continues to lose money. Over the four quarters to June 30, 2026, revenue was $769 million, climbing 52.5% from a year earlier. At the same time, the operating loss held near $223 million but shrank as a share of revenue. The operating loss came to 29.1% of revenue, down from 44.1% a year before, representing the narrowest loss of any twelve-month stretch since mid-2021.

Even with a smaller operating loss as a share of revenue, more cash is leaving the business. Free cash flow was negative $371 million over those four quarters, expanding from negative $204 million a year earlier.

For now, the company holds the cash needed to absorb that outflow. Rocket Lab reported $2.30 billion in cash and short-term investments at June 30, 2026, against just $134 million of debt. That available cash amounts to about six times the past year's free cash outflow. The company also bolstered its balance sheet by raising $1.08 billion in the second quarter through the sale of new shares. On the August 10 call, management stated that the money is meant for acquisitions such as the pending purchase of Iridium, alongside general corporate spending.

Neutron Is Late, And Costly For Rocket Lab

The Neutron rocket program has fallen behind schedule. On the August 10 call, management noted that production progress lined up with getting Neutron to the launch pad in the fourth quarter of 2026. At the same time, the window for an actual launch by year-end was narrowing. Management also said developing and producing the new rocket means cash consumption will stay elevated. Capital spending will also stay high as the company works toward the first flight.

Profitability is facing near-term pressure. Management expects a lower gross margin in the third quarter, guiding GAAP gross margin to 29% to 31%. That marks a step down from a GAAP gross margin of 36.1% in the second quarter. Reuters reported on August 10 that the third-quarter margin forecast fell below Wall Street expectations. According to the report, higher costs tied to ramping up launch services and space-systems production weighed on profitability.

Is Too Much Of Your Wealth Riding On One Stock?

Rocket Lab holders have just seen how hard one stock can fall. When one position grows into a large part of your wealth, a sharp fall can hurt your whole plan, and selling to spread the money out can bring a large tax bill. Glenn Caldicott, CIO of our Boston-based partner firm Empirical Asset Management, an SEC-registered investment adviser, offers a free 15-minute strategy review of ways to protect a concentrated position and unwind it with less tax.

Request A Free Strategy Review